课题基金 / 基金详情

Development and validation of a Parallel Artificial Membrane Assay Permeation model for personal care formulations

Development and validation of a Parallel Artificial Membrane Assay Permeation model for personal care formulations
个人护理配方平行人工膜测定渗透模型的开发和验证
批准号:
2870236
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Excised human skin is the most preferred approach for the assessment of topical formulations using in vitro skin permeation studies. The major challenges in using excised human skin are (1) the difficulty in sourcing the skin samples and (2) intra- and inter-specimen variability (Dick and Scott, 1992; Schmook et al., 2001). Several alternative models have been developed for prediction of skin permeation for chemicals. One of these models, the skin Parallel Artificial Membrane Permeation Assay (PAMPA) model has been investigated for prediction of the skin permeation of several molecules. The skin PAMPA membrane is essentially a filter substrate coated with synthetic lipids arranged in 96-well plate and allows for rapid and high-throughput screening of compounds. Recently, the UCL group has performed comparative studies for permeation in the skin PAMPA membrane and in human tissue under finite dose conditions for caffeine, ibuprofen and niacinamide. Very good correlations were observed for cumulative amounts of active permeated over time in the PAMPA model compared with conventional in vitro permeation studies with animal tissue. However, it is important to note that to date, very simple formulations e.g. single or binary solvent systems have been investigated in the PAMPA model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金